Inventor profile of:

Peter Rhode

City:

Culver City, California

Country:

United States

Published Applications:

18

Last publication date:

2026-05-21

Top Assignees for applications by Peter Rhode

The entities that hold a legal rights for patent applications filed by inventor Rhode Peter:

Recent patent applications by Rhode Peter

Peter Rhode from Culver City, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21
US20260137757A1
Human necessities

IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

#2 | 2026-03-05
US20260061033A1
Human necessities

IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

#3 | 2025-08-21
US20250262278A1
Human necessities

IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

#4 | 2025-08-21
US20250262277A1
Human necessities

IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

#5 | 2025-02-27
US20250066442A1
Chemistry; metallurgy

FUSION MOLECULES AND IL-15 VARIANTS

#6 | 2024-09-19
US20240307495A1
Human necessities

BCG and IL-15 based molecules

#7 | 2024-09-19
US20240307494A1
Human necessities

IL-15-based molecules with anti-CD20 antibody and methods of use

#8 | 2024-09-12
US20240299498A1
Human necessities

METHOD FOR STIMULATING TUMOR-INFILTRATING LYMPHOCYTES WITH AN IL-15:IL-15R COMPLEX

#9 | 2024-08-08
US20240261373A1
Human necessities

IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

#10 | 2024-08-01
US20240252591A1
Human necessities

Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)

#11 | 2024-04-25
US20240131115A1
Human necessities

Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody

#12 | 2023-08-17
US20230257437A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

#13 | 2023-08-03
US20230241175A1
Human necessities

IL-15-based molecules and methods of treating a neoplasia

#14 | 2023-08-03
US20230241174A1
Human necessities

Method of treating cancer with composition comprising IL-15-based molecules and BCG

#15 | 2023-07-27
US20230233649A1
Human necessities

Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex

#16 | 2023-06-22
US20230190877A1
Human necessities

Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies

#17 | 2022-09-29
US20220305087A1
Human necessities

IL-15-based molecules and methods of use thereof

#18 | 2022-09-08
US20220281937A1
Chemistry; metallurgy

Fusion molecules and IL-15 variants

InventorID:

5511108 ⎘